The Safer Prescription of Opioids Tool USA Market feasibility study

更安全的阿片类药物处方工具美国市场可行性研究

• 批准号: 10018146
• 金额: $ 2.67万
• 依托单位: DOCTOR FLINT LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=10018146
• 关键词: Safer; Prescription; Opioids; Tool; USA

SPOT - The Safer Prescription of Opioids Tool is a novel digital health platform, distributed as software as a service, which is proven to significantly improve the confidence of opioid prescribing and adherence to best practice guidelines. SPOT has been featured by the BBC and is one of SDI's top 12 Digital Health innovations to watch in 2020\. SPOT has been included in the Scottish Government's Coronavirus 19 palliative care response toolkit.Following a recent IUK project, SPOT has partnered with a UK and European-based professional publishing distributor, Class Professional Publishing. As of April 2021, SPOT is now available Europe-wide on their Salesforce platform, complemented with first-line sales and technical support.Building on specific contacts engendered over the last two years, our progress in the UK and European markets, and an increase in momentum for digital health from the COVID-19 pandemic, we seek to carry out a feasibility study with potential commercial partners in the USA who have already expressed interest in SPOT.

SPOT - 更安全的阿片类药物处方工具是一个新颖的数字健康平台，以软件即服务的形式分发，事实证明，它可以显着提高阿片类药物处方的信心和对最佳实践指南的遵守。 SPOT 已被 BBC 重点报道，是 SDI 2020 年值得关注的 12 项数字健康创新之一。 SPOT 已被纳入苏格兰政府的冠状病毒 19 姑息治疗应对工具包。继最近的 IUK 项目之后，SPOT 与英国和欧洲的专业出版发行商 Class Professional Publishing 合作。截至 2021 年 4 月，SPOT 现已在欧洲范围内的 Salesforce 平台上推出，并辅以一线销售和技术支持。基于过去两年建立的具体联系、我们在英国和欧洲市场的进展以及 COVID-19 大流行带来的数字健康势头的增强，我们寻求与已对 SPOT 表示兴趣的美国潜在商业合作伙伴进行可行性研究。